Your browser doesn't support javascript.
loading
High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone.
Heintel, Daniel; Rocci, Alberto; Ludwig, Heinz; Bolomsky, Arnold; Caltagirone, Simona; Schreder, Martin; Pfeifer, Sabine; Gisslinger, Heinz; Zojer, Niklas; Jäger, Ulrich; Palumbo, Antonio.
Afiliación
  • Heintel D; Department of Internal Medicine I, Center for Oncology and Haematology, Wilhelminenspital, Vienna, Austria.
  • Rocci A; Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliera S. Giovanni Battista, Ospedale Molinette, Torino, Italy.
  • Ludwig H; Department of Internal Medicine I, Center for Oncology and Haematology, Wilhelminenspital, Vienna, Austria.
  • Bolomsky A; Department of Internal Medicine I, Center for Oncology and Haematology, Wilhelminenspital, Vienna, Austria.
  • Caltagirone S; Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliera S. Giovanni Battista, Ospedale Molinette, Torino, Italy.
  • Schreder M; Department of Internal Medicine I, Center for Oncology and Haematology, Wilhelminenspital, Vienna, Austria.
  • Pfeifer S; Department of Internal Medicine I, Center for Oncology and Haematology, Wilhelminenspital, Vienna, Austria.
  • Gisslinger H; Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna (MUW), Vienna, Austria.
  • Zojer N; Department of Internal Medicine I, Center for Oncology and Haematology, Wilhelminenspital, Vienna, Austria.
  • Jäger U; Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna (MUW), Vienna, Austria.
  • Palumbo A; Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliera S. Giovanni Battista, Ospedale Molinette, Torino, Italy.
Br J Haematol ; 161(5): 695-700, 2013 Jun.
Article en En | MEDLINE | ID: mdl-23565715

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptido Hidrolasas / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Br J Haematol Año: 2013 Tipo del documento: Article País de afiliación: Austria Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptido Hidrolasas / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Mieloma Múltiple Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Br J Haematol Año: 2013 Tipo del documento: Article País de afiliación: Austria Pais de publicación: Reino Unido